Literature DB >> 11698147

Hypoxanthine-guanine phosphoribosyltransferase-deficiency produces aberrant neurite outgrowth of rodent neuroblastoma used to model the neurological disorder Lesch Nyhan syndrome.

G P Connolly1.   

Abstract

Lesch Nyhan syndrome (LNS) manifests in bizarre and horrific neurological symptoms, the primary cause being a deficiency of the purine salvage enzyme, hypoxanthine-guanine phosphoribosyltransferase (HGPRT). How and why this enzyme deficiency leads to abnormal brain development is unknown. To investigate this phenomenon the present study was designed to examine if the growth of two HGPRT-deficient neuroblastomas, mouse N2aTG and rat B103-4C was different with respect to their corresponding control cell lines, N2a and B103. Data is provided showing that compared to control cell lines, HGPRT-deficient cells proliferated less and exhibited greater morphological complexity. If these abnormalities occur during neurogenesis of human HGPRT-deficient brain neurones, they could profoundly influence central nervous system development and thus, may form the aetiological basis for the symptoms of LNS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698147     DOI: 10.1016/s0304-3940(01)02290-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Hypoxanthine deregulates genes involved in early neuronal development. Implications in Lesch-Nyhan disease pathogenesis.

Authors:  R J Torres; J G Puig
Journal:  J Inherit Metab Dis       Date:  2015-05-05       Impact factor: 4.982

2.  Impairment of adenylyl cyclase 2 function and expression in hypoxanthine phosphoribosyltransferase-deficient rat B103 neuroblastoma cells as model for Lesch-Nyhan disease: BODIPY-forskolin as pharmacological tool.

Authors:  Liz Kinast; Juliane von der Ohe; Heike Burhenne; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-03       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.